Anatara Lifesciences Limited announced that Executive Chairman, Dr. Melvyn John Bridges has informed the Board of his wish to retire from his role at Anatara with immediate effect and the Board has formally accepted his resignation. As a result, Dr. Jay Hetzel, Non-Executive Director has been appointed Interim Chairman; Dr. Tracie Ramsdale, Executive Director has been appointed Interim CEO; and Mr. Iain Ross and Mr. Paul Grujic will continue as Non-Executive directors. The company ceased Melvyn John Bridges to be director on 17 May 2018.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.039 AUD | -4.88% | -18.75% | +77.27% |
May. 01 | Anatara Lifesciences Raises AU$1 Million via Shares Placement; Shares Decline 6% | MT |
Apr. 09 | Anatara Lifesciences Begins Recruitment for Irritable Bowel Syndrome Stage Two Trial | MT |
1st Jan change | Capi. | |
---|---|---|
+77.27% | 4.55M | |
+29.98% | 684B | |
+30.34% | 568B | |
-3.52% | 361B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B |
- Stock Market
- Equities
- ANR Stock
- News Anatara Lifesciences Ltd
- Anatara Lifesciences Limited Announces Executive Changes